Lead Identification to Clinical Candidate Selection | Semantic Scholar
Clinical Candidate Selection | Applied BioMath
Discovery of MCLA-158, the first clinical candidate screened in organoids targeting cancer stem cells of solid tumors
Clinical Candidate Selection | Applied BioMath
Where Do Recent Small Molecule Clinical Candidates Come From? - Drug Hunter
Crown Bioscience: First Clinical Candidate Developed Using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer | Business Wire
GNA NOW - IMI AMR Accelerator
Drug discovery - Wikipedia
Requirements for a lead compound to become a clinical candidate | Semantic Scholar
Small Molecules
Where Do Recent Small Molecule Clinical Candidates Come From? - Drug Hunter
A summary of the information to be developed before the selection of a... | Download Scientific Diagram
A novel pre-clinical antibacterial pipeline database | PLOS ONE
Clinical Candidate - Aperus Pharma
STORM Therapeutics selects first-in-class clinical candidate targeting METTL3 - Seroba Life Sciences
Excelya - {A real-time dashboard of clinical trials for COVID-19} In response to the global coronavirus disease 2019 (COVID-19) emergency, clinical trial research assessing the efficacy and safety of clinical candidate interventions
Lead Compound Requirements To Become a Clinical Candidate | Main Heading, LCC
Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its Novel Psilocybin-Inspired Clinical Candidate - Psilocybin Alpha
How Much Longer Will We Put Up With $100,000 Cancer Drugs?: Cell
PCC | Insilico Medicine
Sosei Heptares Announces That The Third Novel Drug Candidate From Its Multi-target Drug Discovery Collaboration With Pfizer Has Started Clinical Trials
Drug development - Wikipedia
Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia - ScienceDirect
The role of mouse tumour models in the discovery and development of anticancer drugs | British Journal of Cancer
EST64454: A Highly Soluble σ1 Receptor Antagonist Clinical Candidate for Pain Management - Biotech Spain
3C-like protease inhibitor clinical candidate, S-217622, as a treatment for SARS-CoV-2
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders | Journal of Medicinal Chemistry
